Photos from: Alzheimer's Association Welcomes Results of New Study




Brain scans show clearance of amyloid plaques, in red, in patients A and B, who received Donanemab, compared to higher levels of amyloid in a patient C, who only received a placebo in Eli Lilly's trial.



Powered by ROAR Online Publication Software from Lions Light Corporation
© Copyright 2024